{"id":510,"date":"2016-12-05T20:45:52","date_gmt":"2016-12-05T20:45:52","guid":{"rendered":"https:\/\/www.drug-injury-lawyer.com\/?page_id=510"},"modified":"2016-12-05T20:45:52","modified_gmt":"2016-12-05T20:45:52","slug":"xarelto","status":"publish","type":"page","link":"https:\/\/www.drug-injury-lawyer.com\/defective-drugs-overview\/xarelto\/","title":{"rendered":"Xarelto"},"content":{"rendered":"<p>Xarelto (rivaroxaban), a Bayer and Johnson &amp; Johnson Janssen Pharmaceutical product is an oral anticoagulant blood thinner that has been on the market since 2011.\u00a0 Xarelto is extremely popular amongst consumers in the United States due to it\u2019s ability to treat a variety of medical issues.\u00a0 These issues include reducing\u00a0 the risk of blood clots and strokes in people with\u00a0 atrial fibrillation;\u00a0 treating deep vein thrombosis and pulmonary embolism; and also reducing the risk of blood clots in patients who recently have had hip or knee replacement surgery.<\/p>\n<p>Unfortunately, \u00a0this drug has been linked to an extensive <em>increased<\/em> risk of internal bleeding.\u00a0 The most dangerous side effect for people who take these medications is <em>uncontrollable<\/em> bleeding.\u00a0 Unlike other blood thinning drugs, Xarelto does <em><u>not<\/u> have an antidote<\/em> <em>or reversal agent to allow physicians to effectively control bleeding problems <\/em>that arise<em>. <\/em>Lawsuits allege the manufacturer of Xarelto failed to provide adequate warnings and communications to the medical community and end line consumers of the increased risk of serious bleeding complications and lack of antidote or reversal agent associated with these drugs.<\/p>\n<p>The case is against the manufacturers of Xarelto \u2013 Bayer, Johnson &amp; Johnson and Janssen Pharmaceutical \u2013 for failure to adequately warn consumer of these adverse consequences, for failure to bring to market an effective antidote or reversal against to stop bleeding, and for defective dosing instructions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xarelto (rivaroxaban), a Bayer and Johnson &amp; Johnson Janssen Pharmaceutical product is an oral anticoagulant blood thinner that has been on the market since 2011.\u00a0 Xarelto is extremely popular amongst consumers in the United States due to it\u2019s ability to &hellip; <a href=\"https:\/\/www.drug-injury-lawyer.com\/defective-drugs-overview\/xarelto\/\">Read More<\/a><\/p>\n","protected":false},"author":12,"featured_media":0,"parent":57,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-510","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/pages\/510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/comments?post=510"}],"version-history":[{"count":1,"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/pages\/510\/revisions"}],"predecessor-version":[{"id":511,"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/pages\/510\/revisions\/511"}],"up":[{"embeddable":true,"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/pages\/57"}],"wp:attachment":[{"href":"https:\/\/www.drug-injury-lawyer.com\/wp-json\/wp\/v2\/media?parent=510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}